Online drug delivery platform PharmEasy has appointed Abhinav Yajurvedi as its chief technology officer (CTO).
Yajurvedi joins from fashion portal Myntra, where he served as senior vice president of engineering until December last year.
“Abhinav contributed immensely to Myntra’s success as a key technology leader, with Myntra recording 40x growth in its revenue during his tenure. He is also credited with proposing and launching the first responsive website for Myntra,” a PharmEasy spokesperson was quoted as saying by The Economic Times.
PharmEasy declined to comment on TechCircle's queries with regard to the appointment.
A graduate of the Indian Institute of Technology-Roorkee and the University of Delhi, Yajurvedi started his career with Trilogy, a company which offers enterprise-class software and service solutions targeted at the automotive industry.
After six years at Trilogy, Yajurvedi moved to e-commerce giant Amazon where he worked as a software development manager for two years. He then spent nearly two years at Myntra.
Owned and operated by Mumbai-based 91 Streets Media Pvt. Ltd, PharmEasy was founded in 2015 by Dharmil Sheth and Dhaval Shah. It connects patients with pharmacies using a tech-enabled lead-generation platform that helps customers get cheaper diagnostic tests. The company competes with the likes of 1mg and Netmeds.
In its most recent funding round, the company received a Series C cheque of $50 million (Rs 363 crore) from investors led by Eight Roads Ventures.
Its other backers include Ascent Health and Wellness Solutions, Bessemer Venture Partners and Orios Venture Partners.
In March 2017, PharmEasy had mopped up $16 million (Rs 105 crore at the time) in a Series B round.